Your Food Brand Is Growing. Is Your Regulatory Risk Growing With It?

Most food founders we talk to share an assumption they rarely say out loud: the product has been selling for years, no one from the FDA has called, so it must be compliant. It is an understandable belief. It is also one of the most expensive ones a growing brand can hold.
The FDA does not pre-approve food labels, and it does not review a product simply because it exists. Silence from the agency is not a compliance finding. It usually means no one has looked closely yet. What growth changes is how many people start looking: national retail buyers, investors running due diligence, plaintiffs' firms scanning shelves, and regulators responding to complaints from a much larger customer base.
Growth also changes the rules themselves. Several federal requirements scale with company size, and several deadlines arrive whether you are ready or not. Below are five regulatory issues that become more consequential as a brand expands into national retail, launches new SKUs, or brings in outside capital, and three of them come with deadlines between now and mid-January.
Years of sales without an FDA letter is not evidence of compliance. It is evidence that no one has looked closely yet.
1. The Exemptions You Started With Have Ceilings
Many early-stage brands are operating, knowingly or not, under size-based exemptions. Two of the most important ones disappear as the business grows.
The first is the small business nutrition labeling exemption. A product can be exempt from Nutrition Facts labeling if the company has fewer than an average of 100 full-time equivalent employees and fewer than 100,000 units of that product are sold in the United States in a 12-month period. But the exemption is not automatic. Unless a company has fewer than 10 employees, is not an importer, and sells fewer than 10,000 units of the product, it must file a notice with the FDA every year. The FDA's own guidance warns that if the agency does not receive the annual notice, the exemption no longer applies, and that the FDA does not remind firms when it is time to file. Adding a nutrient content claim to the package can also take a product outside the exemption.
The second is qualified facility status under the Preventive Controls for Human Food rule. A very small business, defined as averaging less than $1 million per year in human food sales plus the market value of food held without sale, adjusted for inflation over the prior three years, is subject only to modified requirements. Cross that line and the facility moves into full hazard analysis and risk-based preventive controls, including a written food safety plan.
Exemption | Where It Ends | What Growth Triggers |
Small business nutrition labeling | 100 or more FTEs, or 100,000 or more units of a product per year | Nutrition Facts panels on affected products, plus new label artwork and nutrient analysis |
Annual exemption notice | Any year the notice is not filed (unless under 10 FTEs and 10,000 units) | Exemption lapses even if the company still qualifies on size |
Qualified facility (very small business) | Average annual food sales of $1 million, adjusted for inflation | Full preventive controls, including a written food safety plan |
Qualified facility attestation | Attestation not filed during the October 1 to December 31, 2026 window | Loss of the documentation supporting modified requirements |
That last row is time-sensitive. On September 29, 2026, the FDA reminded industry that qualified facilities must submit their attestation during the same biennial window as registration renewal, which closes December 31, 2026.
2. The Label That "Has Always Worked" Was Never Reviewed
Because no one approves a food label in advance, the first real review of many labels happens at the worst possible time: during retailer onboarding, during an investor's diligence, or after a consumer complaint.
Allergen declarations are where this hurts most. The Minnesota Department of Agriculture notes that undeclared allergens are the most common cause of food recalls in the United States, often because of packaging and labeling errors. Sesame became the ninth major food allergen on January 1, 2023, and labels designed before then are worth a second look.
Growth multiplies the exposure. Every new flavor, pack size, or co-manufacturing line is a new label, often built by copying an old one. A single mistake that once affected one SKU sold regionally can now affect a dozen SKUs in national distribution, which is the difference between a correction and a recall.
Every line extension starts as a copy of an existing label. If the original was never reviewed, every copy inherits its problems.
3. Claims That Worked at the Farmers Market Do Not Scale
Small brands often build their identity on attractive front-of-pack language. At national scale, those words are read by more consumers, more competitors, and more lawyers.
Some of those words now have precise federal definitions. The FDA's final rule updating the "healthy" nutrient content claim, published December 27, 2024, ties the claim to food group and nutrient criteria, requires manufacturers to keep records for foods bearing the claim in certain cases, and has a compliance date of February 25, 2028.
Brands using "healthy," or derivatives like "healthier," in a nutritional context should be checking products against the new criteria now rather than redesigning packaging in 2027.
Claims also interact with the exemptions above. A brand relying on the small business nutrition labeling exemption that adds "high protein" or "low sugar" to its packaging may have just made a claim that requires full nutrition labeling. Marketing decisions and regulatory status are connected in ways that are easy to miss when a team is moving fast.
4. Ingredient Deadlines Do Not Care How Big You Are
Expanding into new states means answering to new legislatures, and the federal ingredient landscape is moving at the same time. Two deadlines arrive in January:
• California, January 1, 2027. The California Food Safety Act (AB 418) prohibits manufacturing, selling, or distributing food in California that contains brominated vegetable oil, potassium bromate, propylparaben, or Red No. 3. A brand that expands into California is subject to it the day its product ships there.
• Federal, January 15, 2027. The FDA revoked the authorization for FD&C Red No. 3 in food, including dietary supplements, and food manufacturers must reformulate by January 15, 2027. The FDA has also asked companies to complete the phase-out sooner where practicable.
Beyond those dates, the FDA's proposed rule to make GRAS notification mandatory, which we covered in September, would require companies to notify the agency of ingredients they have been using under self-affirmed GRAS conclusions. Comments close December 9, 2026. A brand planning new SKUs built on novel ingredients should know the regulatory basis for each one before the formula is locked.
5. The Paper Trail Becomes the Product
At a certain size, a food company's documentation is examined almost as closely as its food. Retailers, insurers, and investors all ask for it, and the FDA can ask for much of it during an inspection.
Start with registration. Every facility that manufactures, processes, packs, or holds food for U.S. consumption must renew its FDA registration between October 1 and December 31 of each even-numbered year, which means now. The FDA has stated that it will consider the registration expired for any facility that fails to renew by December 31, 2026. If you use a co-manufacturer, its lapsed registration becomes your supply chain problem in January.
Traceability is next. The FDA's Food Traceability Rule, which requires additional recordkeeping for foods on the Food Traceability List, now has a compliance date of July 20, 2028. That is enough time to build the systems properly and not enough time to postpone starting.
Finally, consider what a buyer or investor will request in diligence: current registrations, food safety plans, supplier approval records, label review files, allergen controls, complaint and recall history, and any FDA correspondence. Gaps in that file do not just create regulatory risk. They create negotiating leverage for the other side of the table.
Investors do not discount your valuation because you had a compliance gap. They discount it because you could not show them you had already found it.
What Growing Food Brands Should Do Now
• Confirm your registration and attestation status before December 31. Renew your own facility registration, confirm that every co-manufacturer and co-packer has renewed, and file a qualified facility attestation if you rely on that status.
• Recheck your size against every exemption you use. Count FTEs and units per product, recalculate average food sales against the FDA's current inflation-adjusted cutoff, and confirm your annual nutrition labeling exemption notices are on file.
• Review every label as if a retailer were reading it for the first time. Start with allergen declarations, including sesame, then move to statements of identity, net quantity, ingredient order, and claims.
• Inventory your claims against current definitions. Pay particular attention to "healthy" and its derivatives, nutrient content claims, and anything that could affect an exemption.
• Screen formulas for January deadlines. Identify any product containing Red No. 3, and any product sold in California containing the substances covered by AB 418.
• Build the diligence file before anyone asks for it. Assemble registrations, food safety plans, supplier records, label approvals, and regulatory correspondence in one place and keep it current.
How Bustos Law Group Supports Growing Food Brands
Bustos Law Group provides specialized FDA legal services for food manufacturers, importers, and distributors nationwide. The firm includes a Lead Instructor for the Food Safety Preventive Controls Alliance with over 18 years of experience in food regulatory matters.
Services include label and claims audits, exemption and qualified facility assessments, preventive controls and food safety plan reviews, co-manufacturer and supplier agreement reviews, regulatory due diligence support for investments and acquisitions, and Warning Letter response strategy.
Growth is the goal. Make sure your compliance program is growing at the same pace.
Schedule a consultation with Bustos Law Group to review your labels, exemptions, and documentation before your next retail launch or funding round.
Sources: U.S. Food and Drug Administration (FDA.gov) | Federal Register | Minnesota Department of Agriculture | California Legislative Information
This blog is for informational purposes only and does not constitute legal advice. For guidance specific to your business, contact Bustos Law Group.



Comments